The AMR Stakeholder Network has published today (23 November) a position paper on the EU Pharmaceutical strategy, with recommendations addressed to the European Commission.
Antimicrobial Resistance (AMR) represents a global health threat, which continues to worsen, despite the emerging realisation of the severity and magnitude of this problem, including beyond expert spheres.
In the document, 18 European organizations, including FEAM, presented six recommendations addressed to the European Commission, on the EU Pharmaceutical strategy:
Read the AMR Stakeholder Network position paper on the EU Pharmaceutical strategy.